Top Markets
#1 Ontology Gas Ontology Gas +45.91%
#2 Verus Coin Verus Coin +22.51%
#3 EXOD EXOD +22.08%
#4 Status Status +19.78%
#5 ETHGas ETHGas +18.84%
#6 Geodnet Geodnet +16.73%
#7 The Black Bull The Black Bull +16.27%
#8 Derive Derive +11.24%
#9 Fake World Assets Fake World Assets +11.05%
#10 Gas Gas +9.27%
Coin of the day
Ontology Gas Ontology Gas
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
AlloVir, Inc. AlloVir, Inc.

AlloVir, Inc.

ALVR
Classificação em ações #25521
AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to... AlloVir, Inc. is a biotechnology company in the clinical stage, dedicated to researching and developing allogeneic, "off-the-shelf" multi-virus specific T-cell (VST) therapies. Its primary goal is to prevent and treat severe diseases caused by viral infections. The company's lead product, posoleucel, is an allogeneic, ready-to-use VST therapy designed to combat several significant viruses, including BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Beyond this flagship candidate, AlloVir's pipeline features additional investigational treatments in various stages of development. These include ALVR106, which targets respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109, developed to address SARS-CoV-2 and COVID-19; ALVR107, for treating hepatitis B; and ALVR108. Established in 2013, the company was initially known as ViraCyte, Inc. before officially rebranding as AlloVir, Inc. in May 2019. Its headquarters are located in Waltham, Massachusetts.
Preço da ação
$9.81
Última sincronização: 2025-03-18
Valor de mercado
$48.68M
Variação (1 dia)
1.55%
Variação (1 ano)
0.00%
País
US
Negociar AlloVir, Inc. (ALVR)

Categoria

Healthcare
Rácio P/B de AlloVir, Inc. (ALVR)
Rácio P/B em August 2026 TTM: 1.68
De acordo com os relatórios financeiros mais recentes e o preço das ações da AlloVir, Inc., o rácio P/B atual (TTM) é 1.68. No final de 2023, o rácio P/B era 0.00.
Histórico do rácio P/B da AlloVir, Inc. de 2022 a 2026
Rácio P/B no final de cada ano
Ano Rácio P/B Alterar
2026 (TTM) 1.68 320.88%
2024 0.40 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
Rácio P/B de empresas semelhantes ou concorrentes
Empresa Rácio P/B Diferença do rácio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 276.71%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 270.73%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 48.82%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 120.30%
US